Men continue to have normal life after radiation for prostate cancer
Men receiving radiation therapy to combat early-stage prostate cancer are still able to achieve an erection and face a low rate of incontinence one year following treatment, according to a new study published in the July 15, 2005 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
Researchers enrolled 98 men from 24 institutions and set out to gauge the health-related quality of life in patients receiving low-dose rate prostate brachytherapy, a form of internal radiation therapy in which tiny radioactive seeds are implanted directly into the prostate gland to battle the cancer.
Patients were given three separate health-related quality of life questionnaires a total of five times before, during and after undergoing radiation therapy to allow researchers to evaluate what effect their treatment was having on them. The two most important side effects studied were sexual and urinary function.
The study reports that one year after receiving treatment, 78 percent of the men were able to achieve an erection, both with and without assistance. However, nearly 50 percent of the men did experience some loss of sexual function, such as reduced desire, activity and satisfaction as well as fatigue.
Although the overall rate of incontinence was low at 1 percent, some men did have difficulty urinating at the one-year mark. Typically, incontinence increases at the beginning of treatment and is completely gone one year after treatment.
"This is the first multi-institutional study of its kind," said Steven J. Feigenberg, M.D., lead author of the study and a radiation oncologist at Fox Chance Cancer Center in Philadelphia. "This study has provided us with valuable data that will help radiation oncologists better address possible side effects patients may have after receiving seed implants for prostate cancer."
For more information on radiation therapy for prostate cancer, please visit http://www.astro.org/patient/treatment_information/ for a free brochure.
To arrange an interview with Dr. Feigenberg or for a copy of the study "Health-Related Quality of Life in Men Receiving Prostate Brachytherapy on RTOG 98-05," please contact Nick Lashinsky at firstname.lastname@example.org or 1-800-962-7876. ASTRO is the largest radiation oncology society in the world, with more than 8,000 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment.
Beth Bukata | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
HZI researchers developed a bacterial strain that can be used in cancer therapy
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...